{"id":"W2772776690","doi":"10.1111/jdv.14738","title":"Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's College Hospital; University of Toronto; Probity Medical Research; Queen's University","funders":"Galderma; Dermira; Celgene; GlaxoSmithKline; Biogen; Kyowa Hakko Kirin; Eli Lilly and Company; Astellas Pharma; Astellas Pharma US; Amgen","keywords":"Apremilast; Medicine; Psoriasis; Etanercept; Dermatology Life Quality Index; Placebo; Dermatology; Internal medicine; Visual analogue scale; Psoriasis Area and Severity Index; Adverse effect; Psoriatic arthritis; Surgery; Tumor necrosis factor alpha; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002814658,0.0003209411,0.00101286,0.00008396696,0.0003707372,0.00001678836,0.0006335266,0.0002560395,0.00003303692],"category_scores_gemma":[0.0001715488,0.0001605443,0.0001074368,0.00007562659,0.0004919965,0.000127506,0.0002419207,0.0004436421,0.000007987649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002768615,"about_ca_system_score_gemma":0.00003750881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008102557,"about_ca_topic_score_gemma":0.0000893679,"domain_scores_codex":[0.9969108,0.001658692,0.000750254,0.0003291222,0.00007163793,0.0002795231],"domain_scores_gemma":[0.9977096,0.0008589641,0.0009837805,0.000350198,0.00005589351,0.00004156795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02385447,0.000677725,0.9579713,0.000007038575,0.001672595,0.00004745699,0.006687489,0.00004759445,0.001676494,0.00005308219,0.0002610323,0.007043705],"study_design_scores_gemma":[0.02027505,0.0006161284,0.970497,0.000184017,0.0005855208,0.0001304376,0.0002983207,0.000001986718,0.006443404,0.0001030654,0.0007038958,0.0001611698],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963237,0.0005620852,0.000007167435,0.00196299,0.000269842,0.0004246733,0.00012971,0.000005593858,0.0003142063],"genre_scores_gemma":[0.9990333,0.0003409377,0.00006353817,0.0002667358,0.00005143521,0.00000308762,0.000009853146,0.0000245046,0.0002065827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01252569,"threshold_uncertainty_score":0.6546806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02100902211503499,"score_gpt":0.2506462612993274,"score_spread":0.2296372391842924,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}